The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period.

@article{Takahashi2010TheKE,
  title={The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period.},
  author={Susumu Takahashi and Kazuyoshi Okada and Mitsuru Yanai},
  journal={Kidney international. Supplement},
  year={2010},
  volume={116},
  pages={S17-23}
}
The International Kidney Evaluation Association Japan evaluated chronic kidney disease (CKD) in Japan, using a Japanese version of the US National Kidney Foundation's Kidney Early Evaluation Program (KEEP). The screening criteria for the first 1065 participants were presence of diabetes or hypertension, or family history of diabetes, hypertension, or kidney disease. Mean age was 59.7+/-16.1 years; 501 participants were men, 564 women. Of participants, 26.9% had diabetes, 59.2% had hypertension… CONTINUE READING

10 Figures & Tables

Connections & Topics

Mentioned Connections BETA
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
The following baseline conditions were significantly associated with discovered CKD : diabetes , odds ratio 1.71 ( 95% confidence interval 1.28 - 2.30 ) ; hypertension , 3.42 ( 2.15 - 5.44 ) ; CVD , 1.88 ( 1.37 - 2.57 ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
The following baseline conditions were significantly associated with discovered CKD : diabetes , odds ratio 1.71 ( 95% confidence interval 1.28 - 2.30 ) ; hypertension , 3.42 ( 2.15 - 5.44 ) ; CVD , 1.88 ( 1.37 - 2.57 ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
CKD ( stages 1 - 4 ) prevalence was 26.7% , defined by albumin - creatinine ratio and estimated glomerular filtration rate .
CKD ( stages 1 - 4 ) prevalence was 26.7% , defined by albumin - creatinine ratio and estimated glomerular filtration rate .
CKD ( stages 1 - 4 ) prevalence was 26.7% , defined by albumin - creatinine ratio and estimated glomerular filtration rate .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
The following baseline conditions were significantly associated with discovered CKD : diabetes , odds ratio 1.71 ( 95% confidence interval 1.28 - 2.30 ) ; hypertension , 3.42 ( 2.15 - 5.44 ) ; CVD , 1.88 ( 1.37 - 2.57 ) .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
The following baseline conditions were significantly associated with discovered CKD : diabetes , odds ratio 1.71 ( 95% confidence interval 1.28 - 2.30 ) ; hypertension , 3.42 ( 2.15 - 5.44 ) ; CVD , 1.88 ( 1.37 - 2.57 ) .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
Of participants , 26.9% had diabetes , 59.2% had hypertension ( with an additional 21.5% diagnosed after the program ) , 16.9% had history of diabetes and hypertension together , and 30.6% had neither , but had family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
The screening criteria for the first 1065 participants were presence of diabetes or hypertension , or family history of diabetes , hypertension , or kidney disease .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
CKD prevalence was 35.0% among diabetic participants , 34.8% among hypertensive participants , and 37.1% among participants with cardiovascular disease ( CVD ) .
The following baseline conditions were significantly associated with discovered CKD : diabetes , odds ratio 1.71 ( 95% confidence interval 1.28 - 2.30 ) ; hypertension , 3.42 ( 2.15 - 5.44 ) ; CVD , 1.88 ( 1.37 - 2.57 ) .
CKD ( stages 1 - 4 ) prevalence was 26.7% , defined by albumin - creatinine ratio and estimated glomerular filtration rate .
All Topics